0001209191-23-033174.txt : 20230531 0001209191-23-033174.hdr.sgml : 20230531 20230531173402 ACCESSION NUMBER: 0001209191-23-033174 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230526 FILED AS OF DATE: 20230531 DATE AS OF CHANGE: 20230531 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Phillips Peggy V CENTRAL INDEX KEY: 0001373026 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34207 FILM NUMBER: 23982327 MAIL ADDRESS: STREET 1: C/O DYNAVAX TECHNOLOGIES CORPORATION STREET 2: 2929 SEVENTH STREET, SUITE 100 CITY: BERKELEY STATE: CA ZIP: 94710 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001029142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330728374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 720 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5108485100 MAIL ADDRESS: STREET 1: 2100 POWELL STREET STREET 2: SUITE 720 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-26 0 0001029142 DYNAVAX TECHNOLOGIES CORP DVAX 0001373026 Phillips Peggy V C/O DYNAVAX TECHNOLOGIES CORPORATION 2100 POWELL STREET, SUITE 720 EMERYVILLE CA 94608 1 0 0 0 0 Common Stock 2023-05-26 4 A 0 5357 0.00 A 38447 D Stock Option (Right to Buy) 11.20 2023-05-26 4 A 0 22500 0.00 A 2030-05-25 Common Stock 22500 22500 D These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of DVAX Common Stock. The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred six months and one day after the Reporting Person no longer provides services to the Company. The reporting person has reported prior awards of restricted stock units in Table II on Form 4. The total reported in Column 5 includes 5,357 newly awarded restricted stock units, 5,357 restricted stock units previously reported in Table II, and 27,733 shares of common stock. This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. Peggy V. Phillips, by /s/ Trevor Dutcher, Attorney-in-Fact 2023-05-31